“cancer” Archives

in
Entry Author Date Location
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston 03/18/19 Texas
Servier Licenses CureMatch Tech for Custom Cancer Drug Treatments 03/15/19 San Diego
CesiumAstro, MAP Health, StoryFit, Hatch Pitch & More Texas Tech 03/15/19 Texas
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Joining AI Drug Discovery Race, Erasca Adds $22M For Cancer Work 03/06/19 San Diego
Precision Bio Preps IPO to Test “Off-the-Shelf” Cancer Cell Therapy 03/04/19 Raleigh Durham
Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington 02/27/19 New York
Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO 02/26/19 Texas
No Details, But AstraZeneca Touts PARP Drug Win in Pancreatic Cancer 02/26/19 New York
FDA Staff Hammers Karyopharm Cancer Drug on Safety, Efficacy Concerns 02/22/19 Boston
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Merck Scooping Up Cancer Drug Developer Immune Design for $300M 02/21/19 New York
Blaze Bio Raises $5M to Help Surgeons See Tumors From Healthy Tissue 02/20/19 Seattle
Peloton Therapeutics Raises $150M to Advance Kidney Cancer Therapy 02/20/19 Texas
Funds for Richard’s Rainwater, New CPRIT Executive, & More TX Tech 02/15/19 Texas
Bayer Snaps Up Rights to Two Cancer Drugs from Lilly’s $8B Loxo Deal 02/15/19 Indiana
TCR²’s IPO Raises $75M to Bring Cancer Cell Therapy to Solid Tumors 02/14/19 Boston
AbbVie Joins Myeloma Race with $90M Deal for Rights to Teneobio Drug 02/11/19 San Francisco
Genomenon Raises $2.5M, Plans to Increase Work with Pharma Customers 02/08/19 Detroit Ann Arbor
Harpoon’s IPO Spears $76M as Prostate Cancer Drug Continues Testing 02/07/19 San Francisco
Hypergiant in Space, Celltex & Saudi, Siete Foods’ $90M, & More TX Tech 02/07/19 Texas
Halozyme Gets $30M from Argenx in Licensing Deal Worth Up to $530M 02/06/19 San Diego
Bolt Bio Bags $54M for Drugs that Turn the Heat Up on “Cold” Tumors 02/05/19 San Francisco
Cancer Cures and the Importance of Communicating Responsibly 02/04/19 San Diego
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More 02/01/19 National
Aduro Biotech Slashes Staff 37%, Turns Focus to Lead Cancer Drugs 01/30/19 San Francisco
Dewpoint Debuts with $60M to Target Protein Droplets Linked to Disease 01/30/19 Boston
In Another Lung Cancer Setback, Bristol Yanks FDA App For Drug Combo 01/24/19 New York
Failed Clinical Trial Puts Eli Lilly Cancer Drug in Limbo 01/18/19 Indiana
Despite Buyout, Celgene Dealmaking Rolls On With Kyn, Obsidian Tie-Ups 01/18/19 Boston
Page 1 of 76 next page »